In ovarian cancer specifically, histone marks such as the repressive H3K27me3 mark and active H3K4me3 mark are considered markers of bivalent genes, poised to be silenced during drug resistance in ovarian cancers, particularly regulated by the EZH2 protein complex [73]. Here, EZH2 is linked to ovarian cancer.